跳至主要内容
临床试验/NCT02097446
NCT02097446Unknown3 期

Safety and Efficacy of Antiadhesive Barrier GUARDIX-FL for Women After Laparoscopic Cystectomy : A Prospective, Randomized, Controlled Study

Genewel Co., Ltd2 个研究点 分布在 1 个国家目标入组 60 人开始时间: 2014年3月27日最近更新:
适应症

试验速览

阶段
3 期
入组人数
60
试验地点
2
主要终点
Anti-Adhesion Rate

研究概览

简要总结

  • Indication: Benign tumors of ovary(mature teratoma, mucinous cystadenoma, serous cystadenoma)
  • Intervention: Device ( Test group : Guardix-FL, Control group : Interceed)
  • Primary Outcome Measure : Anti-adhesion Rate
  • Assessment : Operative Day(Visit 2), Post-Operative Day+7days(Vist 3), Post-Operative Day+4weeks(Visit4), Post-Operative Day+5weeks(Visit 5)

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Supportive Care
盲法
Triple (Participant, Care Provider, Investigator)

入排标准

年龄范围
18 Years 至 44 Years(Adult)
性别
Female
接受健康志愿者

入选标准

  • The patients who sign the written informed consent
  • Women aged between 18 and 44
  • The patients who are able to participate in clinical trial during the period of study
  • The patients without abnormal figures at the screening laboratory examination
  • The patients expecting ovarian cystectomy for benign ovarian tumor(mature cystic teratoma, Mucinous cystadenoma, serous cystadenoma)

排除标准

  • The patients who took treatments with medical products which might be barrier to evaluate the effectiveness
  • The patients who took medicine like other anti-adhesion, absorbable hemostat and dose of steroid, immunosuppressants
  • The patients with severe drug allergy
  • The patients with infectious disease on abdominal or pelvic cavity
  • The patients who previously participated in another clinical trials within the past 30 days
  • The patients considered inappropriate for the study
  • The pregnant
  • The patients with severe renal disease
  • The patients with severe systemic diseases

结局指标

主要结局

Anti-Adhesion Rate

时间窗: Post-Operative Day+4weeks(Second - look)

Adhesion yes or no

次要结局

  • Score(Post-Operative Day+4weeks(Second-look))

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验